Cargando…

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People

Detalles Bibliográficos
Autores principales:	Lopes, Luciane Cruz, Benko, Ria, Oliveira, Marcio Galvão, Paniz, Vera Maria Vieira, Godman, Brian, Motter, Fabiane Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199432/ https://www.ncbi.nlm.nih.gov/pubmed/35721158 http://dx.doi.org/10.3389/fphar.2022.941813

Ejemplares similares

Pain and Inflammation Management in Older Adults: A Brazilian Consensus of Potentially Inappropriate Medication and Their Alternative Therapies
por: Motter, Fabiane Raquel, et al.
Publicado: (2019)

Potentially inappropriate prescriptions to Brazilian older people with Alzheimer disease: A cross-sectional study
por: Ferreira, Tânia Regina, et al.
Publicado: (2021)

Regular access and adherence to medications of the specialized component of pharmaceutical services
por: Fritzen, Janaína Soder, et al.
Publicado: (2017)

Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use
por: Lopes, Luciane Cruz, et al.
Publicado: (2020)

Healthcare professionals’ knowledge, attitudes and practices toward deprescribing: a protocol of cross-sectional study (Desmedica Study—Brazil)
por: Motter, Fabiane Raquel, et al.
Publicado: (2021)

Design and validity of an instrument to assess healthcare professionals’ perceptions, behaviour, self-efficacy and attitudes towards evidence-based health practice: I-SABE
por: Ruano, Arielly Souza Mariano, et al.
Publicado: (2022)

Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
por: Pedroso, José Victor de Miranda, et al.
Publicado: (2021)

Editorial: New Horizons in Health-Promoting: From Methods to Implementation Science
por: Barberato-Filho, Silvio, et al.
Publicado: (2022)

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit
por: Lima, Elisangela da Costa, et al.
Publicado: (2020)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Frequency and Severity of Adverse Drug Reactions to Medications Prescribed for Alzheimer’s Disease in a Brazilian City: Cross-Sectional Study
por: Ferreira, Tânia Regina, et al.
Publicado: (2020)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review
por: Nagem Lopes, Luis Phillipe, et al.
Publicado: (2023)

Drug utilization research in Peru: Is real-world data available?
por: Rodríguez-Tanta, L. Yesenia, et al.
Publicado: (2023)

Editorial: Women in pharmacoepidemiology: 2021
por: Lopes, Luciane Cruz, et al.
Publicado: (2023)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2023)

Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs
por: Daali, Youssef, et al.
Publicado: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Editorial: Pharmaceutical policy, impact and health outcomes
por: Kwon, Hye-Young, et al.
Publicado: (2023)

Editorial: Computational chemogenomics: In silico tools in pharmacological research and drug discovery
por: Sánchez-Cruz, Norberto, et al.
Publicado: (2023)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: structural plasticity induced by drugs of abuse
por: Olive, M. Foster, et al.
Publicado: (2015)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Editorial: Women in drug metabolism and transport: 2021
por: Bregonzio, Claudia, et al.
Publicado: (2022)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Editorial: Advancements in computational studies of drug toxicity
por: Flynn, Noah R., et al.
Publicado: (2023)

Editorial: Insights in drug metabolism and transport: 2021
por: Piñeiro-Llanes, Janny, et al.
Publicado: (2023)

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
por: Kwon, Hye-Young, et al.
Publicado: (2018)

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy
por: Fulone, Izabela, et al.
Publicado: (2020)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Editorial: Monitoring endogenous GPCRs: lessons for drug design
por: Massotte, Dominique
Publicado: (2015)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_46sbev3u6049mi2a8p9k7psrn1